Evaluation of atipamezole as a treatment for dexmedetomidine-induced cardiovascular depression in anesthetized cats

Kathryn K. Zatroch 1Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853

Search for other papers by Kathryn K. Zatroch in
Current site
Google Scholar
PubMed
Close
 DVM
,
Daniel M. Sakai 1Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853

Search for other papers by Daniel M. Sakai in
Current site
Google Scholar
PubMed
Close
 DVM
,
Stephen Parry 2Cornell University Statistical Consulting Unit, College of Human Ecology, Cornell University, Ithaca, NY 14853

Search for other papers by Stephen Parry in
Current site
Google Scholar
PubMed
Close
 MS
,
Luis Campoy 1Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853

Search for other papers by Luis Campoy in
Current site
Google Scholar
PubMed
Close
 DVM
, and
Manuel Martin-Flores 1Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853

Search for other papers by Manuel Martin-Flores in
Current site
Google Scholar
PubMed
Close
 DVM

Abstract

OBJECTIVE

To evaluate the cardiovascular effects of atipamezole administered at half the volume or the same volume as dexmedetomidine to isoflurane-anesthetized cats.

ANIMALS

6 adult (1 to 2 years old) domestic shorthair cats (body weight, 3 to 6 kg).

PROCEDURES

Each cat was anesthetized with isoflurane and rocuronium 3 times; there was a 1-week washout period between successive anesthetic procedures. For each anesthetic procedure, dexmedetomidine (5 μg/kg) was administered IV. Five minutes after dexmedetomidine was administered, atipamezole (25 or 50 μg/kg) or saline (0.9% NaCl) solution was administered IM. Pulse rate, mean arterial blood pressure (MAP), cardiac output (CO), and systemic vascular resistance (SVR) were measured during anesthesia before dexmedetomidine administration (baseline), after dexmedetomidine administration, and 15, 30, 60, and 120 minutes after administration of atipamezole or saline solution. Pulse rate and MAP were also recorded when MAP was at its lowest value. Hemodynamic variables were compared among treatments at baseline, after dexmedetomidine administration, and after administration of atipamezole or saline solution. Effects of treatment and time on all variables were assessed with mixed-effects models.

RESULTS

Both doses of atipamezole resulted in a significantly lower MAP than did saline solution. Pulse rate, CO, and SVR were not significantly different among treatments after atipamezole or saline solution were administered.

CONCLUSIONS AND CLINICAL RELEVANCE

Atipamezole administered IM at half the volume or the same volume as dexmedetomidine was ineffective at increasing pulse rate or CO in anesthetized cats that received dexmedetomidine. However, atipamezole caused short-lasting but severe arterial hypotension.

Abstract

OBJECTIVE

To evaluate the cardiovascular effects of atipamezole administered at half the volume or the same volume as dexmedetomidine to isoflurane-anesthetized cats.

ANIMALS

6 adult (1 to 2 years old) domestic shorthair cats (body weight, 3 to 6 kg).

PROCEDURES

Each cat was anesthetized with isoflurane and rocuronium 3 times; there was a 1-week washout period between successive anesthetic procedures. For each anesthetic procedure, dexmedetomidine (5 μg/kg) was administered IV. Five minutes after dexmedetomidine was administered, atipamezole (25 or 50 μg/kg) or saline (0.9% NaCl) solution was administered IM. Pulse rate, mean arterial blood pressure (MAP), cardiac output (CO), and systemic vascular resistance (SVR) were measured during anesthesia before dexmedetomidine administration (baseline), after dexmedetomidine administration, and 15, 30, 60, and 120 minutes after administration of atipamezole or saline solution. Pulse rate and MAP were also recorded when MAP was at its lowest value. Hemodynamic variables were compared among treatments at baseline, after dexmedetomidine administration, and after administration of atipamezole or saline solution. Effects of treatment and time on all variables were assessed with mixed-effects models.

RESULTS

Both doses of atipamezole resulted in a significantly lower MAP than did saline solution. Pulse rate, CO, and SVR were not significantly different among treatments after atipamezole or saline solution were administered.

CONCLUSIONS AND CLINICAL RELEVANCE

Atipamezole administered IM at half the volume or the same volume as dexmedetomidine was ineffective at increasing pulse rate or CO in anesthetized cats that received dexmedetomidine. However, atipamezole caused short-lasting but severe arterial hypotension.

All Time Past Year Past 30 Days
Abstract Views 283 0 0
Full Text Views 2081 1349 124
PDF Downloads 1532 822 71
Advertisement